PAMPA

MS Marjolein Soethoudt
UG Uwe Grether
JF Jürgen Fingerle
TG Travis W. Grim
FF Filomena Fezza
LP Luciano de Petrocellis
CU Christoph Ullmer
BR Benno Rothenhäusler
CP Camille Perret
NG Noortje van Gils
DF David Finlay
CM Christa MacDonald
AC Andrea Chicca
MG Marianela Dalghi Gens
JS Jordyn Stuart
HV Henk de Vries
NM Nicolina Mastrangelo
LX Lizi Xia
GA Georgios Alachouzos
MB Marc P. Baggelaar
AM Andrea Martella
EM Elliot D. Mock
HD Hui Deng
LH Laura H. Heitman
MC Mark Connor
VM Vincenzo Di Marzo
JG Jürg Gertsch
AL Aron H. Lichtman
MM Mauro Maccarrone
PP Pal Pacher
MG Michelle Glass
MS Mario van der Stelt
request Request a Protocol
ask Ask a question
Favorite

PAMPA (Parallel Artificial Membrane Permeability Assay) is a method which determines the permeability of substances from a donor compartment, through a lipid-infused artificial membrane into an acceptor compartment. Read-out is a permeation coefficient Peff drug as well as test compound concentrations in donor, membrane and acceptor compartments67.

A 96-well microtiter plate completely filled with aqueous buffer solutions (pH 7.4/ 6.5) is covered with a microtiter filterplate like a sandwich construction. The hydrophobic filter material (Durapore/Millipore; pore size 0.22–0.45 μm) of the first 48 wells (sample) of the filterplate is impregnated with a 1–20% solution of lecithin in an organic solvent (dodecane, hexadecane, 1,9-decadiene). The filter surface of the remaining 48 wells (reference) is wetted with a small volume (4–5 μl) of a 50% (v/v) methanol/buffer solution. Transport studies were started by the transfer of 100–200 μl of a 250 or 500 μM stock solution on top of the filterplate in the sample and in the reference section, respectively. In general 0.05 M TRIS, pH 7.4, or 0.05 M phosphate, pH 6.5, buffers were used. The maximum DMSO content of the stock solutions was 5%.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A